COMBINED PHARMACO-FEVER TREATMENT WITH IMIPRAMINE (TOFRĀNIL) AND TYPHOID VACCINE IN THE MANAGEMENT OF DEPRESSIVE CONDITIONS
Abstract
Imipramine (Tofrānil) therapy and artificial pyrexia obtained through the intravenous administration of typhoid vaccine in gradually increasing amounts were combined in the therapeutic management of special clinical problems encountered in depressed patients. Shortening of the time lag between the start of treatment and first significant improvement, a final favourable response in patients who at first had proved refractory to the drug and therapeutic control of acutely suicidal patients were the criteria for successful responses. These special criteria were met in 15 of our 28 patients (58%) subjected to pharmaco-fever therapy. It is assumed that the mechanism which contributed to a favourable response include the physiological lowering of the blood-brain barrier with a resulting increase of drug concentration in the target organ. On the psychological side, the unspecffic anxiety-reducing effects of pyrexia are noted as well as the facilitation of clinical and nursing management of acutely suicidal patients if they are confined to bed with a recurring fever of moderate degree.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
